For the 13th consecutive year, the ACS Pharma Leaders Meeting brought together the pharmaceutical industry’s chemistry research leaders to discuss issues and challenges of common concern.
Executives representing 12 companies attended the meeting, which was held Oct. 22–23, 2015, at Merck & Co.’s Rahway, N.J., facility.
Coorganized by Merck and ACS Industry Member Programs, this year’s meeting was again aimed at exploring areas of mutual interest and possible collaborations on precompetitive and noncompetitive issues.
With the common goal of accelerating drug development, the group explored the possibility of creating a consortium to share chemical building blocks and the potential benefits of sharing or commercializing tool compounds—highly selective chemical probes that help researchers determine the biological function of a given target...I didn't know that this happened, but it seems smart. I wonder if Dr. Zaluchi from Detroit ever gets to talk.